:: RK Global ::

Company Profile

Quarterly Results

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business SupportHouse : Sun Pharma

BSE147.4011.2 (+8.22 %)

PREV CLOSE ( ) 136.20

OPEN PRICE ( ) 134.95

BID PRICE (QTY) 147.40 (3491)

OFFER PRICE (QTY) 147.60 (1)

VOLUME 395098

TODAY'S LOW / HIGH ( )134.15 153.05

52 WK LOW / HIGH ( )108.2 204.25

NSE147.4511.29 (+8.29 %)

PREV CLOSE( ) 136.16

OPEN PRICE ( ) 134.41

BID PRICE (QTY) 147.36 (92)

OFFER PRICE (QTY) 147.40 (862)

VOLUME 9133926

TODAY'S LOW / HIGH( ) 134.41 153.00

52 WK LOW / HIGH ( )108 204.4

(Rs.in Million)

Particulars

Dec 2025

Sep 2025

Jun 2025

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

84.50

78.60

96.40

271.90

Total Expenditure

650.90

735.80

617.20

803.70

PBIDT (Excl OI)

-566.40

-657.20

-520.80

-531.80

Other Income

0.10

91.40

Operating Profit

-566.40

-657.10

-429.40

-531.80

Interest

87.80

75.20

61.90

45.40

Exceptional Items

-123.60

PBDT

-777.80

-732.30

-491.30

-577.20

Depreciation

25.70

25.60

26.80

29.50

Profit Before Tax

-803.50

-757.90

-518.10

-606.70

Tax

0.70

0.60

-9.00

Provisions and contingencies

Profit After Tax

-804.20

-758.50

-518.70

-597.70

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

-804.20

-758.50

-518.70

-597.70

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

-804.20

-758.50

-518.70

-597.70

Equity Capital

324.50

Face Value (IN RS)

1.00

Reserves

Calculated EPS

-2.48

-2.34

-1.60

-1.84

Calculated EPS (Annualised)

-9.91

-9.35

-6.39

-7.37

No of Public Share Holdings

111406493.00

% of Public Share Holdings

34.33

PBIDTM% (Excl OI)

-670.30

-836.13

-540.25

-195.59

PBIDTM%

-670.30

-836.01

-445.44

-195.59

PBDTM%

-920.47

-931.68

-509.65

-212.28

PBTM%

-950.89

-964.25

-537.45

-223.13

PATM%

-951.72

-965.01

-538.07

-219.82

Notes

Call Us +91 -33 40142930

Email Us care.kolkata@rkglobal.in

Corporate Office Flat No.5 Sagar Apartment 6 Tilak Marg, New Delhi 110 001

Attention Investors

Prevent unauthorised Transactions in your account —> Update your mobile numbers/email 10s with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...... Issued in the interest of Investors Prevent Unauthorized Transactions in your demat account—> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day Issued in the interest of investors. No need to issue cheques by investor while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of

KYC

KYC KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DR Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Compliance Officer : Mr. Kamesh Gupta. 011-43100999. kgupta@rkglobal.in / grievances@rkglobal.in - File a Complaint on SCORES

Registration Nos : SEBI Registration No . INZ000187132; Research Regn. No. : INH000002210; IN-DP-241-2016; NSDL: DP ID - IN 302453 (Delhi), IN 302951 (Kolkata); R K Global Shares & Securities Ltd CIN NO:U99999MH1995PTC174185;

Filing Complaints on SCORES - Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID. Benefits: Effective Communication, Speedy redressal of the grievances.

Company

Quick LInks

Designed,Developed & Content Powered by Accord Fintech Pvt Ltd.